Metrics
Publication
66
UN Sustainable Development Goals
Education
1990 - 1993
1990 - 1993Post Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler İç Hastalıkları Abd Hematoloji Bilim Dalı, Turkey
1981 - 1985
1981 - 1985Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler İç Hastalıkları Abd, Turkey
1973 - 1979
1973 - 1979Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
1985
1985Expertise In Medicine
Akut Lösemilerin Tanısında Sitoşimik Yöntemler
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler İç Hastalıkları Abd
Research Areas
Medicine
Health Sciences
Internal Medicine Sciences
Internal Diseases
Hematology
Immunology and Rheumatology
Academic Positions
2003 - Present
2003 - PresentProfessor
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler
1997 - 2003
1997 - 2003Associate Professor
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler
1993 - 1997
1993 - 1997Research Assistant PhD
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler
1993 - 1993
1993 - 1993Research Assistant PhD
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler
1990 - 1993
1990 - 1993Expert
Istanbul University, Istanbul Medical Faculty, Dahili Bilimler
Managerial Experience
2013 - 2016
2013 - 2016Head of Department
İstanbul Üniversitesi, İç Hastalıkları Abd, Dahili Bilimler
Articles
All (29)
SCI-E, SSCI, AHCI (27)
SCI-E, SSCI, AHCI, ESCI (28)
ESCI (1)
Scopus (26)
TRDizin (6)
Other Publications (1)
2020
20201. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
KUMAN TUNÇEL Ö., Kayikcioglu M., PIRILDAR Ş., YILMAZ M., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY
, vol.14, no.3, pp.361-372, 2020 (SCI-Expanded)
2020
20202. Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis
Kater A., Panagiotis P., Aktan M., ARSLAN Ö., DEMİRKAN F., Enggaard L., et al.
LEUKEMIA & LYMPHOMA
, vol.61, pp.113-115, 2020 (SCI-Expanded)
2019
20193. Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Study
Hindilerden I. Y., Erciyestepe M., Nalcaci M., Kalayoglu-Besisik S., Sargin D., Aktan M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.19, 2019 (SCI-Expanded)
2019
20194. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
Kayikcioglu M., Kuman-Tuncel O., Pirildar S., YILMAZ M., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY
, vol.13, no.3, pp.455-467, 2019 (SCI-Expanded)
2019
20195. Identification of red blood cell membrane defects in a patient with hereditary spherocytosis using next-generation sequencing technology and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Sener L., Aktan M., Albeniz G., Sener A., Üstek D., Albeniz I.
MOLECULAR MEDICINE REPORTS
, vol.19, no.5, pp.3912-3922, 2019 (SCI-Expanded)
2018
20186. Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study
Leblond V., Aktan M., Ferra Coll C. M., Dartigeas C., Kisro J., Montillo M., et al.
HAEMATOLOGICA
, vol.103, no.11, pp.1889-1898, 2018 (SCI-Expanded)
2018
20187. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M., Tokgozoglu L., DOĞAN V., CEYHAN C., TUNÇEZ A., KUTLU M., et al.
ATHEROSCLEROSIS
, vol.277, pp.341-346, 2018 (SCI-Expanded)
2018
20188. Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Michallet A., Aktan M., Hiddemann W., İLHAN O., Johansson P., Laribi K., et al.
HAEMATOLOGICA
, vol.103, no.4, pp.698-706, 2018 (SCI-Expanded)
2018
20189. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
Kayikcioglu M., Tokgozoglu L., YILMAZ M., KAYNAR L., Aktan M., Durmus R. B., et al.
ATHEROSCLEROSIS
, vol.270, pp.42-48, 2018 (SCI-Expanded)
2018
201810. Dramatic Reduction of LATS2 Tumor Suppressor Protein Expression in Patients with CLL: Evaluation of LATS2 Levels with Clinical Features and Immunophenotypic Profile
Sert E., Coskunpinar E., Yenerel M. N., Aktan M., Ozturk D., Ozturk O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.28, no.3, pp.137-146, 2018 (SCI-Expanded)
2016
201611. Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression
Isiksacan N., Cinar S., Cetin E., Aktan M., Deniz G.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.3, pp.202-208, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201612. Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia
Ayer M., Sakin A., Ay S., Ayer A., Sazak E. G., Aktan M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.4, pp.335-338, 2016 (SCI-Expanded)
2015
201513. Hereditary spherocytosis associated with defects of human red blood cell membrane
Albeniz I., Sener L. T., Albeniz G., Aktan M., ÜSTEK D.
ACTA PHYSIOLOGICA
, vol.215, pp.123, 2015 (SCI-Expanded)
2015
201514. Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study
Michallet A., Aktan M., Schuh A., Widenius T., Johansson P., Raposo J., et al.
LEUKEMIA & LYMPHOMA
, vol.56, pp.149, 2015 (SCI-Expanded)
2015
201515. Incidence of JAK2V617F Mutation in Patients with Acute Myeloid Leukemia
Ozcam H., Aktan M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.25, no.1, pp.19-23, 2015 (SCI-Expanded)
2014
201416. The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience
Yenerel M. N., Aktan M., Yildiz A., Caliskan Y., Nalcaci M.
BLOOD
, vol.124, no.21, 2014 (SCI-Expanded)
2013
201317. Analysis of gene copy number changes in chronic lymphocytic leukemia
Dalay N., Isin M., ÇETİN G., Aktan M.
CANCER RESEARCH
, vol.73, 2013 (SCI-Expanded)
2012
201218. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients
Hancer V. S., Diz-Kucukkaya R., Aktan M.
MEDICAL ONCOLOGY
, vol.29, no.2, pp.1068-1072, 2012 (SCI-Expanded)
2011
201119. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia
Hancer V. S., Kose M., Diz-Kucukkaya R., Yavuz A., Aktan M.
LEUKEMIA & LYMPHOMA
, vol.52, no.1, pp.79-84, 2011 (SCI-Expanded)
2010
201020. Psychogenic Purpura with Hematuria and Sexual Pain Disorder: A Case Report
Ozyildirim I., Yucel B., Aktan M.
TURK PSIKIYATRI DERGISI
, vol.21, no.1, pp.85-89, 2010 (SSCI)
2007
200721. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
YENEREL M. N., Atamer T., Ayer M., Yildirim N. D., Kucukkaya R. D., Yavuz A. S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.70, no.1, pp.6-10, 2007 (ESCI)
2006
200622. Detection of 11q23 and 13q14 deletions in patients with chronic lymphocytic leukemia by fluorescence in situ hybridization method
KARAHAN G. E., AKTAN M., AYDIN F., ÇINAR Ç., OĞUZ F., ÇARİN M.
Adv Mol Med , no.2, pp.131-137, 2006 (Peer-Reviewed Journal)
2005
200523. Genotoxicity and sister chromatid exchange in patients with myelodysplastic disorders.
Oztürk S., PALANDUZ S., CEFLE K., TUTKAN G., UCUR A., DINCOL G., et al.
Cancer genetics and cytogenetics
, vol.159, pp.148-50, 2005 (SCI-Expanded)
2004
200424. Real-Time PCR analysis of af4 and dek genes expression in acute promyelocytic leukemia t (15;17) patients.
SAVLI H., Sirma S., NAGY B., Aktan M., Dincol G., SALCIOGLU Z., et al.
Experimental & molecular medicine
, vol.36, pp.279-82, 2004 (SCI-Expanded)
2003
200325. Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients.
SAVLI H., Sirma S., Nagy B., Aktan M., Dincol G., OZBEK U.
Experimental & molecular medicine
, vol.35, pp.454-9, 2003 (SCI-Expanded)
2003
200326. Quantification of All-Trans-Retinoic Acid (ATRA) Dependent Expression of CXCR4 Gene in Acute Promyelocytic Leukaemia.
SAVLI H., Sırma S., Aktan M., Dınçol G., OZBEK U.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.20, pp.153-9, 2003 (SCI-Expanded)
2002
200227. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study
Yeneral M. N., Atamer T., YAVUZ A. F., Kucukkaya R., BEŞIŞIK S., Aktan M., et al.
ANNALS OF HEMATOLOGY
, vol.81, no.9, pp.498-503, 2002 (SCI-Expanded)
2000
200028. Chimerism status in allo-pbsct versus allo-BMT: single center results
Uzbek U., Kalayoglu-Besisik S., Aydin M., Yenerel M. N., Aktan M., Budak T., et al.
Blood
, vol.96, 2000 (SCI-Expanded)
1997
199729. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients
Yazici H., SENGUN Z., AKTAN M., AKTUGLU G., USKENT N., DALAY N.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
, vol.16, no.1, pp.105-109, 1997 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2020
20201. Utilization of Radiation Therapy and Predictors of Noncompliance among Syrian Refugees with Cancer Living in Turkey
Sayan M., Eren M. F., Kotek A., Kaplan S. O., Duran O., Cukurcayir F., et al.
62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 October 2020, vol.108
2018
20182. Kronik Lenfositik Lösemili (KLL) Hastalarda STAT3 Protein ve IL-10 Sitokin Düzeylerinin Araştırılması
ÖZCAN Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
İmmünolojide Moleküller Sempozyumu, İzmir, Turkey, 18 October 2018 - 21 October 0018, pp.1, (Full Text)
2018
20183. BATF levels in chronic lymphocytic leukemia patients
GELMEZ M. Y., ÇINAR S., Özçit G., Yanal I., Dağlar Aday A., DENİZ G., et al.
Abstracts of the 5th European Congress of Immunology-ECI 2018, Amsterdam, Netherlands, 2 - 05 September 2018, vol.P.A3.01.20, pp.145, (Full Text)
2018
20184. Chronic lymphocytic leukemia: Increased IL-10 and STAT3 levels in B cells
ÖZCAN Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
Abstracts of the 5th European Congress of Immunology-ECI 2018, Amsterdam, Netherlands, 2 - 05 September 2018, vol.P.A3.03.09, pp.150, (Full Text)
2018
20185. Chronic Lymphocytic Leukaemia: Increased IL-10 and STAT3 Levels in B cells
ÖZCAN Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
5th European Congress of Immunology, Amsterdam, Netherlands, 2 - 05 September 2018, pp.150, (Full Text)
2018
20186. Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey
Amikishiyev S., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., Sargin D., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567, (Summary Text)
2018
20187. Secondary primary malignancies after autologuous hematopoietic stem cell transplantation: Single center experience
Tekin D., Dagci G., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.368-369, (Summary Text)
2017
20178. KRONİK LENFOSİTİK LÖSEMİLİ HASTALARDA HÜCRE İÇİ IL-10 DÜZEYLERi
Özcan Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
20179. Kronik Lenfositik Lösemili Hastalarda BATF Ekspresyonunun Araştırılması
GELMEZ M. Y., ÇINAR S., Dağlar Aday A., Özçit G., Yönal İ., DENİZ G., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.20-21, (Full Text)
2017
201710. KRoNİK LENFosiTİK LÖsEMİLİ HASTALARDA HücRE İÇİ IL-10 DÜZEYLERi
ÖZCAN Ö., GELMEZ M. Y., DENİZ G., ÇINAR S., AKTAN M.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.215, (Full Text)
2017
201711. Kronik Lenfositik Lösemili Hastalarda Hücre İçi IL-10 Düzeyleri
Özcan Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
XXIV. Ulusal İmmünoloji Kongresi, Turkey, 27 - 30 April 2017, (Summary Text)
2017
201712. Kronik Lösemili hastalarda hücre içi IL_10 düzeyleri
ÖZCAN Ö., GELMEZ M. Y., ÇINAR S., DENİZ G., AKTAN M.
XXIV. Ulusal İmmünoloji Kongresi, İstanbul, Turkey, 27 - 30 April 2017, pp.48, (Full Text)
2017
201713. BATF Ekspresyonunun Kronik Lenfositik Lösemili Hastalarda Araştırılması
GELMEZ M. Y., ÇINAR S., Dağlar Aday A., Özçit G., Yönal İ., DENİZ G., et al.
24. Ulusal İmmünoloji Kongresi, İstanbul, Turkey, 27 - 29 April 2017, pp.6, (Summary Text)
2016
201614. Kronik Lenfositik Lösemili Hastalarda BATF Düzeyinin Saptanması
GELMEZ M. Y., ÇINAR S., ADAY A., Özçit G., YÖNAL İ., DENİZ G., et al.
8.DETAE GÜNLERİ, İstanbul, Turkey, 15 - 16 December 2016, pp.1, (Summary Text)
2015
201515. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria
Erkek E. T., Nazligul E., Nalcaci M., Aktan M., Yenerel M. N.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
2015
201516. The Role of mir-93 and mir-155 expressions in AID Regulation in Chronic Lymphocytic Leukemia
GELMEZ M. Y., ÇOŞKUNPINAR E. M., DENİZ G., AKTAN M.
23. Ulsal İmmünoloji Kongresi, Viyana, Austria, 6 - 09 September 2015, (Full Text)
2015
201517. Changes in AID, Dicer and Drosha mRNA Levels in Chronic Lymphocytic Leukemia Patients with Chromosomal Deletions
GELMEZ M. Y., ÇOŞKUNPINAR E. M., DENİZ G., AKTAN M.
4. European Congress of Immunology, Viyana, Austria, 6 - 09 September 2015, (Full Text)
2015
201518. Hereditary Spherocytosis associated with defects of human red blood cell membrane
ALBENİZ I., TÜRKER ŞENER L., ALBENİZ G., AKTAN M., ÜSTEK D.
The Joint Meeting of the FEPS and the Baltic Physiological Societies (FEPS 2015), Kaunas, Lithuania, 26 - 29 August 2015, pp.122, (Full Text)
2015
201519. Kronik Lenfositik Lösemili (KLL) Hastalarda mir-93 ve mir-155 ile AID Regülasyonu Arasındaki İlişki
GELMEZ M. Y., ÇOŞKUNPINAR E. M., DENİZ G., AKTAN M.
23. Ulsal İmmünoloji Kongresi, Antalya, Turkey, 26 - 29 April 2015, pp.81, (Full Text)
2015
201520. ZAP70 ve CD38 belirteçlerinin KLL hastalarında incelenmesi
Işıksaçan N., ÇINAR S., ÇETİN E., AKTAN M., DENİZ G.
23. Ulusal İmmünoloji Kongresi, Antalya, Turkey, 26 - 30 April 2015, pp.80, (Full Text)
2015
201521. Kronik Lenfositik Lösemili (KLL) Hastalarda Gözlenen Delesyonların Araştırılması
GELMEZ M. Y., ÇOŞKUNPINAR E. M., DENİZ G., AKTAN M.
23. Ulsal İmmünoloji Kongresi, Antalya, Turkey, 26 - 30 April 2015, pp.79, (Full Text)
2015
201522. ZAP70 ve CD38 Belirtec lerinin KLL hastalarında İncelenmesi
Işıksaçan N., ÇINAR S., ÇETİN E., AKTAN M., DENİZ G.
23. Ulusal İmmünoloji Kongresi, Turkey, 26 - 30 April 2015
2013
201323. Analysis of gene copy number changes in chronic lymphocytic leukemia
DALAY M. N., IŞIN M., Cetin G., AKTAN M.
Chromatin and Epigenetics in Cancer, Washington Dc, United States Of America, 6 - 10 April 2013, vol.73, no.13, (Full Text)
2012
201224. Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).
Leblond V., Laribi K., İLHAN O., Aktan M., ÜNAL A., Rassam S. M. B., et al.
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120, (Summary Text)
2012
201225. Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?
Dermenci H., Daglar A., Akadam B. P., Hancer V. S., Gelmez Y., Aktan M., et al.
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120, (Summary Text)
2012
201226. Analysis Of Aid Mrna Levels In Cll Patients With Different Cytogenetic Status
GELMEZ M. Y., ADAY A., AKADAM-TEKER B., DENİZ G., AKTAN M., SOYSAL T.
MIMIC, Antalya, Turkey, 27 - 30 April 2012, (Summary Text)
2011
201127. Investigation of lncRNAs in chronic lymphocytic leukemia and prostate cancer
IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.
7th NCRI Cancer Conference, United Kingdom, 1 - 04 November 2011, pp.49, (Full Text)
2011
201128. 17p13, 11q22.3, 13q14 Ve 13q34 Delesyonu Olan Ve Olmayan Kronik Lenfositik Lösemili (Kll) Hastalarda Aid Gen Ekspresyon-Mutasyon Düzeyinin Araştırılması
GELMEZ M. Y., ADAY A., AKADAM B., DENİZ G., AKTAN M., SOYSAL T.
36. Ulusal Hematoloji Kongresi, Ankara, Turkey, 19 - 22 October 2011, pp.11, (Summary Text)
2011
201129. Investigation of plasma lncRNA levels in chronic lymphocytic leukemia and multiple myeloma patients
IŞIN M., Özgür E., AKTAN M., ERTEN S. N., GEZER U., DALAY M. N.
7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19, (Full Text)
2011
201130. Kronik Lenfositik Lösemili Hastalarda P53 Geni Ekzon 6 Değişikliklerinin İncelenmesi
IŞIN M., AKTAN M., BUYRU A. N., DALAY M. N.
XIX. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.482, (Full Text)
2011
201131. Kronik lenfositik lösemili hastaların plazmalarında serbest kodlamayan RNA’ların araştırılması
IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.
IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.376, (Full Text)
2009
200932. Polisitemia Veralı Hastalarda Cr-51 ile Eritrosit Kitle İndekslerinin (EKİ) Klinik Parametrelerle Karşılaştırılması
ADAY H. S., ADAY A., TÜRKMEN C., AKTAN M.
21. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 2 - 05 May 2009, no.18, (Full Text)
2009
200933. Kronik Lenfositik Lösemili Hastalarda p53 P14ARF ve HDM2 Gen İfade Düzeyleri
IŞIN M., YENEREL M. N., AKTAN M., BUYRU A. N., DALAY N.
XVIII. Ulusal Kanser Kongresi, Antalya, Antalya, Turkey, 21 - 26 April 2009, pp.194, (Full Text)
2006
200634. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.
Yenerel M. N., Diz-Kucukkaya R., Demirel N., Ayer M., Yavuz S., Besisik S., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)
2005
200535. The Influence of HLA in Turkısh Chronic Lymphocyte Leukemia Patients and A Familial Association
DİLER A. S., TOZKIR H., ŞENTÜRK ÇİFTÇİ H., KILIÇASLAN AYNA T., OĞUZ F., GÜRTEKİN M., et al.
31th ASHI Annual Meeting American Society For Histocompatibility and Immunogenetic, 17 - 21 October 2005, (Summary Text)
2000
200036. Myeloid/Natural Killer Cell Acute Leukemia: A Case Report
Turgut M., GELİNCİK A., YENEREL M. N., Köroğlu G., AKTAN M., Pekçelen Y.
5th Annual Meeting of The European Haematology Association, Birmington, United Kingdom, 25 - 28 June 2000, pp.106, (Full Text)
Other Publications
2014
20141. İnsan eritrosit membran proteinlerin deki eksiklikler ve morfolojik bozukluklar
TÜRKER ŞENER L., AKTAN M., Üstek D., ŞENER A., ALBENİZ I.
Other, pp.72-73, 2014
Funded Projects
2012 - 2015
2012 - 2015Tüylü Hücreli Lösemide V600E Mutasyonunun Araştırılması
Project Supported by Higher Education Institutions , BAP PhD
AKTAN M. (Executive)
2013 - 2014
2013 - 2014KRONİK LENFOSİTİK LÖSEMİLİ (KLL) HASTALARDA AID PROTEİN DÜZEYİNİN VE MİKRORNA İLİŞKİSİNİN ANALİZİ
Project Supported by Higher Education Institutions , BAP PhD
AKTAN M. (Executive)
2012 - 2013
2012 - 2013Akut miyeloid lösemili hastalarda JAK2V617F mutasyonu sıklığının araştırılması
Project Supported by Higher Education Institutions , BAP PhD
AKTAN M. (Executive)
2010 - 2012
2010 - 201217p13, 11q22.3 ve 13q34 delesyonu olan ve olmayan Kronik Lenfositik Lösemili (KLL) hastalarda AID gen ekspresyon-mutasyon düzeyinin araştırılması
Project Supported by Higher Education Institutions , BAP MSc
AKTAN M. (Executive)
2008 - 2011
2008 - 2011AID (Aktivasyonla indüklenen sitidin deaminaz) Geninin Ekspresyon Düzeyi ile Kronik Lenfositik Löseminin Prognozu Arasındaki İlişkinin araştırılması
Project Supported by Higher Education Institutions , BAP PhD
AKTAN M. (Executive)